CHU Angers - Hôpital Hôtel Dieu#

Angers, Maine Et Loire 49933 Angers Cedex 09

1 studies enrolling now · 2 studies all time

What they study most

First Line Non-Small Cell Lung Cancer, Secondary Immune Deficiency

Studies at this site

• Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies — Starting soon
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed